14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Session II : Receptor <strong>signaling</strong> <strong>and</strong> G proteins Poster II, 17<br />

Functional overlapping between caspase cleavage site <strong>and</strong> CBL binding sequence in the<br />

juxtamembrane domain of the MET receptor.<br />

Julien DEHEUNINCK, Catherine LEROY, Zongling JI, Bénédicte FOVEAU, Vincent<br />

VILLERET, David TULASNE <strong>and</strong> Véronique FAFEUR<br />

CNRS UMR 8117, Institut de Biologie de Lille, Institut Pasteur de Lille, B.P.447, 59021<br />

Lille, FRANCE. E-mail : veronique.fafeur@ibl.fr<br />

Hepatocyte growth factor/ scatter factor (HGF/SF) binds <strong>and</strong> activates the MET tyrosine<br />

kinase receptor to transduce cell survival. Nonetheless, we previously demonstrated that stress<br />

stimuli cause a caspase-dependent cleavage in the MET juxtamembrane domain, which<br />

converts MET into a pro-apoptotic p40 MET fragment. The caspase 3 cleavage occurs at<br />

aspartic acid residue D1000. This residue is juxtaposed to tyrosine Y1001, which is rather<br />

involved in binding CBL upon MET activation by its lig<strong>and</strong>, allowing MET trafficking <strong>and</strong><br />

recycling. We wished to examine the functional relationships between caspase-dependent<br />

cleavage <strong>and</strong> CBL binding at the ESVDY sequence of the juxtamembrane domain of MET.<br />

We first established that the caspase cleavage- <strong>and</strong> CBL binding- sites overlapped, since a<br />

MET D1000N mutant lost the ability both to generate p40 MET <strong>and</strong> to recruit CBL. We then<br />

individually mutated all amino acids of the ESVDY sequence of MET constituting the<br />

caspase <strong>and</strong> CBL sites. While a MET V999A mutant was selectively defective in generating<br />

p40 MET, a MET Y1001F mutant was selectively defective in recruiting CBL, demonstrating<br />

that caspase-dependent cleavage <strong>and</strong> CBL recruitment are dissociable mechanisms. We<br />

further examined the consequence of MET phosphorylation at CBL binding site on the<br />

caspase-dependent cleavage. Using in vitro MET phosphorylation <strong>and</strong> dephosphorylation, we<br />

demonstrated that generation of p40 MET is unfavored when MET is phosphorylated, <strong>and</strong><br />

vice versa. These data were strengthened by modeling studies using the MET peptide<br />

sequence ESVDYR <strong>and</strong> the known structure of caspase 3 or CBL in complex with specific<br />

peptide sequences. These studies show that a phosphorylated Y1001 is not compatible with<br />

specific association of caspase-3 to MET <strong>and</strong> also exclude simultaneous fixation of both<br />

caspase 3 <strong>and</strong> CBL to MET.<br />

In conclusion, we demonstrated that the caspase-dependent cleavage of MET <strong>and</strong> binding of<br />

CBL to the activated MET receptor are dissociable <strong>and</strong> incompatible mechanisms. As a<br />

consequence, we propose that HGF/SF can protect MET against caspase-dependent cleavage<br />

by activating autophosphorylation of the receptor.<br />

- 144 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!